10th Edition of World Congress on Infectious Diseases
June 25-27, 2026 | Barcelona, Spain
Broad Spectrum Antibiotic
Broad Spectrum Antibiotics are a class of antimicrobial agents designed to target a wide range of bacteria, providing efficacy against both Gram-positive and Gram-negative organisms. These antibiotics play a crucial role in medical treatment, offering a versatile approach to combating various bacterial infections. By inhibiting essential cellular processes within bacteria, they effectively hinder bacterial growth and replication. One notable example of a broad-spectrum antibiotic is Amoxicillin, which belongs to the penicillin group. Amoxicillin is effective against a diverse array of bacteria, making it a commonly prescribed antibiotic for respiratory, urinary tract, and skin infections. Its ability to target both Gram-positive and Gram-negative bacteria enhances its utility in treating a broad spectrum of microbial infections.
Francis J Castellino
University of Notre Dame, United States
Ranjan Ramasamy
ID-FISH Technology, United States
Yazdan Mirzanejad
University of British Columbia, Canada
Alexis Torres Rodriguez
NewYork-Presbyterian Queens Hospital, United States
Sasha Leibholz
New York Presbyterian Columbia/Cornell, United States
Hana Raza
Mclaren Oakland Hospital, United States
Terri Menser
Mayo Clinic, United StatesSubmit your abstract Today
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation